Skip to content

Clinical trials

Phase 1/2 Liver Cirrhosis trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Liver Cirrhosis Phase: Phase 1/2 Country / region: China Clear all

13 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20092
20103
20124
20141
20181
20201
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Unknown status8
Completed3
Recruiting1
Suspended1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Air Force Military Medical University, China3
AMERICAN ORGAN TRANSPLANT AND CANCER RESEARCH INSTITUTE LLC1
Alliancells Bioscience Corporation Limited1
Beijing 302 Hospital1
First Affiliated Hospital Xi'an Jiaotong University1
General Hospital of Chinese Armed Police Forces1
Nanjing Medical University1
Qingdao University1
S-Evans Biosciences Co., Ltd.1
Shenzhen Beike Bio-Technology Co., Ltd.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Liver Cirrhosis13
End Stage Liver Disease3
Liver Diseases2
Digestive System Diseases1
Fatty Liver1
Fibrosis1
Hypertension, Portal1
Liver Failure1
Liver Neoplasms1
Thrombosis1

Trials

Showing 1 to 13 of 13. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.